Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Los términos de búsqueda han de ser en inglés.

Laboratorio holandés ofrece experiencia en inmunología para colaboración internacional en el campo de diagnóstico in vitro y desarrollo de vacunas

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TONL20180810001
Publicado:
31/08/2018
Caducidad:
01/09/2019
Resumen:
Una pyme holandesa ofrece su experiencia e instalaciones de ensayos celulares para suministrar nuevos ensayos de diagnóstico in vitro (IVD) y vacunas para infecciones bacterianas. La empresa ha desarrollado un ensayo de inmunidad mediada por células para Coxiella (fiebre Q) y tiene amplia experiencia en pruebas y validación de la enfermedad de Lyme. Su objetivo es establecer acuerdos de investigación o participar como socio en la solicitud de una subvención en el marco de un acuerdo de licencia, cooperación en materia de investigación o servicio. La empresa también ofrece asistencia en investigación, validación clínica y lanzamiento al mercado/marcado CE de ensayos de diagnóstico in vitro y programas de desarrollo de vacunas.

Details

Tittle:
Dutch laboratory offers immunology expertise for international collaboration on in vitro diagnostic and vaccine development
Summary:
A Dutch SME is offering their expertise and facilities on cellular testing to provide new in vitro diagnostic (IVD) tests and vaccines for bacterial infections.
The company has developed a cell-mediated immunity test for Coxiella (Q fever) and has broad experience in Lyme disease testing and validation.
They are open for contract research assignments or as SME partner in a grant application in the frame of a license agreement, a research cooperation agreement or a services agreement.
Description:
The Dutch SME is a young research intensive organization. They are experts on cellular testing with years of experience in the pharmaceutical and diagnostics industry. They work closely with patient organizations and university medical centers contributing to meaningful and scientifically sound innovations. The SME focuses on intracellular infections and provides new insights in the immune response against those bacterial infections.
Their mission is to significantly reduce health problems associated with infectious diseases such as for example Q fever and Lyme disease. They do so by (co-)developing diagnostic tests that allow for adequate and timely treatment. The SME also provides support in research, clinical validation and market launch/CE certification of IVD tests and in vaccine development programs.
The company has its own laboratory facilities with biosafety cabinets, general lab equipment, ELISA (Enzyme-Linked Immuno Sorbent Assay) readers and washers, centrifuges, gel electrophoresis -Y- western-blotting equipment, an MSD (Meso Scale Discovery) Quickplex for measuring T-cell responses and ELISPOT (Enzyme-Linked ImmunoSpot assay) reader.

The laboratory provides knowledge on diagnostics, immunology and product development to international consortia such as vaccine development programs and Horizon2020 projects.
The clinical laboratory has direct access to human samples.
The company is experienced in assessing B-cell and T-cell responses to vaccines, validating new diagnostic tests, e.g. for Lyme Borreliosis.

The company is offering their expertise and facilities on cellular immunity testing and is looking for partners to provide new solutions for bacterial infections.

They are open for cooperation in the frame of a license agreement, research cooperation agreement or a services agreement.
Advantages and Innovations:
The company has developed the worlds´ only CE-marked human interferon-gamma release assay for Coxiella. This assay will show the long-lasting T-cell memory response to Coxiella, which does provide a detailed answer on the level of exposure to Coxiella. This is of great value in pre-vaccination screening, which currently requires a skin test and serology.

The company has developed an in-house Q fever immunoblot that is more sensitive than the current standard. The Q fever immunoblot will provide a higher sensitivity, a simplified workflow and a less qualitative interpretation in respect to the current standard.

The clinical laboratory has direct access to human samples and a sample collection related to tick-borne infectious diseases and Q fever.
Stage of Development:
Already on the market
IPs:
Secret Know-how,Patent(s) applied for but not yet granted,Patents granted,Trade Marks,Exclusive Rights
CommeR Statunts Regarding IPR Status:
· Patent on Interferon-gamma Release Assay for Coxiella (Q fever) granted
· Patent on antigen mix for diagnosing Lyme Disease granted
· Patent applied for on incubation device in latest Horizon2020 FTI project ID-LYME

Partner sought

Type and Role of Partner Sought:
· For license agreements: Diagnostics companies in need of new products
· For R-Y-D cooperation: Coordinators/partners in grant applications such as Horizion2020
· For Services: Collaboration partners looking to outsource R-Y-D or validation activities

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
Dutch
English
German

Keywords

Technology Keywords:
06002002 Biología celular y molecular
06001005 Diagnósticos, diagnosis
06002007 Ensayos in vitro, experimentos
06001006 Vacunas humanas